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Summary: An improved assay for quantification of urinary porphyrins by use of second-derivative spectroscopy
is described. A new method for calculation of the porphyrin concentration is developed and the whole
procedure is computerized. Acidified urine samples can be assayed within a few minutes by using this method.
Precision and recoveries for both uro- and coproporphyrin are good. The method is presented as a very fast
and accurate assay for the screening and quantification of urinary porphyrins.
Introduction
Disorders of the haem biosynthetic pathway can give
rise to a group of diseases known as the porphyrias.
Diagnosis rests on the combination of a typical clin-
ical picture and the detection of excess amounts of
excreted porphyrins or their precursors (1). Quanti-
fication of urinary porphyrins is possible by using
several Chromatographie methods (2 — 7). However,
as porphyria is a very rare disease, the main goal
when determining urinary porphyrins is to exclude
porphyria as the cause of an unexplained illness. For
this purpose rapid screening-tests were developed by
Schmitt (8) and Jones & Sweeney (9), by using second-
derivative spectroscopy, and recently more accurate
spectrofluorometric methods (10, 11) have come into
use. In our study we have improved the spectropho-
tometric method of Jones & Sweeney (9) to achieve a
rapid and accurate method for quantitative determi-
nation of total porphyrins in urine and estimation of
the molar fractions of uroporphyrin and copropor-
phyrin.
Materials and Methods
Uroporphyrin I and coproporphyrin III methyl esters were
purchased from Sigma Chemical Co., UK. After hydrolysis of
the esters in HC1 (6 mol/1) for 5 days, standard solutions of
uroporphyrin and coproporphyrin were prepared in 1 mol/1
HC1 and the concentrations were established spectrophoto-
metrically by use of the extinction coefficients of Falk (12).
Absorbance spectra between 245 and 375 nm were recorded
versus water as the optical reference, using a 2000 UV/VIS
spectrophotometer (Bausch and Lomb Analytical Systems Div.,
Rochester, NY, USA). The instrument was equipped with a
flowcell and had a slit-width of 2 nm. The absorbance data (A)
were transmitted through a RS-232 interface to a HP-85 mi-
crocomputer (Hewlett Packard Co., Corvallis, OR, USA). The
computer generated absorbance data at 0.4 nm intervals, using
a scanspeed of 50 nm/min. At this setting both the accuracy
and the speed of the scan were satisfactory. A computer pro-
gram was written to generate first- and second-derivatives
(dA/dl and d2A/dX2) in respect to wavelength (λ). Derivatives
were computed as differences between absorbances. As the
accuracy of this method is very much dependent on the value
of Δλ used to calculate the derivatives, experiments were done
to find the optimal value.
Test mixtures of standard solutions were prepared of various
concentrations of total porphyrins and of various proportions
of uroporphyrin and coproporphyrin. According to Jones &
Sweeney (9), both the magnitude of the second-derivative de-
flection and the wavelength at which the minimum occurs are
dependent on the proportions of uroporphyrin and copropor-
phyrin in the solution. By extensively measuring our test mix-
tures, the uroporphyrin/coproporphyrin ratio was established
as a function of the wavelength of the second-derivative mini-
mum. Instead of the size of the deflection we used the area
under the x-axis above the second-derivative curve as a measure
for the total porphyrin concentration. The area was calculated
for each ratio of uro- and coproporphyrin at a total concen-
tration of 1 μηιοΐ. This 'second-derivative absorptivity' was
established as a function of the uroporphyrin/coproporphyrin
ratio.
Urine specimens were prepared by diluting 1.0 ml aliquots of
centrifuged urine (2000 min"1, 5 min) with 4.0 ml of HC1 (1.25
mol/1) containing the sodium salt of EDTA (1.0 mmol/1). To
convert porphyrinogens into porphyrins, 50 μΐ of hydrogen
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peroxide solution (270 g/1) were added. After determining the
wavelength of the second-derivative minimum and measuring
the area under the x-axis, the uroporphyrin/coproporphyrin
ratio and the 'second-derivative absorptivity' were known and
porphyrin concentrations could be calculated. All calculations
were added to the computer program so that it would finally
give figures for total porphyrin concentration, uro- and copro-
porphyrin molar fractions and uro- and coproporphyrin con-
centrations.
Analytical recovery, precision and interference studies were
carried out by accepted protocols (13). The analytical range of
our method was determined. To verify recent critical reports
(10) on the oxidation procedure used here we compared the
effectiveness of oxidation by H2O2 and iodine at various con-
centrations. We compared results from our method with those
of Horchner & Rietveld (14) using high performance liquid
chromatography (HPLC) and with those of Doss (15) using
ion-exchange chromatography. All urine specimens were pre-
served by the method recommended by Fernandez-Cano &
Labbe (16).
Results
The first- and second-derivative spectra were very
much influenced by the value of Δλ used (fig. 1).
When assaying a urine sample of low porphyrin con-
centration the use of low values for Δλ caused much
disturbance in the first- and second-derivative spectra.
On the other hand, the use of high values for Δλ gave
rise to a shift in the first-derivative spectrum when
assaying urine samples with a rapidly rising back-
ground absorbance. In many of those cases the sec-
ond-derivative minimum failed to correspond to the
absorbance maximum, leading to incorrect estima-
tions of the uro- and coproporphyrin fractions. We
found a value of 8.0 nm to be the optimal Δλ for use
in our assay.
Table 1 shows the wavelength of the second-derivative
minimum (λ-min) and the 'second-derivative absorp-
tivity' at different porphyrin compositions. As our
computer generates absorbance data at 0.4 nm inter-
vals, the given values for λ-min are not mean values,
but the measurement points closest to the mean values
Tab. 1. Wavelength of the second-derivative minimum and 'sec-




































































* The magnitude of those values is proportional to porphyrin
concentration but in absolute terms depends upon the op-
erating conditions of the computer.
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Fig. 1. Absorption spectrum (a) of a urine sample with low porphyrin concentration; second-derivative spectra generated by
using a Δλ of 4.0 nm (b) and 8.0 nm (c);
absorption spectrum (d) of a urine sample with a high porphyrin concentration, and its first-derivative spectra (e, f)
generated by using a Δλ of 16.0 nm (e) and 8.0 nm (f).
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Tab. 2. Analytical recovery of uro- and coproporphyrin.
Urine Added Measured Recovered Recov-
^™Ple (μΐ/ml) (nmol/1) ^nmo1^ ^nmol/1> ^
Uroporphyrin (n = 4 each)
1 0 0 71 - -
1 50 307 382 311 101
1 100 614 660 589 96
2 0 0 173 -
2 50 300 451 278 93
2 100 600 763 590 98
3 0 0 463 - -
3 50 296 748 285 96
3 100 592 1023 560 95
Coproporphyrin (n = 4 each)
4 ο 0 72 - -
4 50 253 323 251 99
4 100 507 569 497 98
5 0 0 213 -
5 50 290 487 274 94
5 100 580 795 582 100
6 0 0 412 - -
6 50 278 677 265 95
6 100 555 962 550 99
Tab. 3. Precision of the method.
Total porphyrins Molar fraction
Mean SD CV Uro- Copro- (SD)
(nmol/1) (%) porphyrin porphyrin
Within-run (n = 10)
61.9 1.8 2.9 0.00 1.00 (0.00)
139.3 2.9 2.0 0.27 0.73 (0.10)
300.3 10.7 3.5 0.08 0.92 (0.08)
1003.0 25.2 2.5 0.73 0.27 (0.06)
8698.4 58.4 0.6 0.90 0.10 (0.00)
Between-run (n = 10)
61.6 1.9 3.0 0.05 0.95 (0.08)
127.5 4.1 3.2 0.14 0.86 (0.09)
311.3 22.4 7.2 0.11 0.89 (0.09)
991.7 21.8 2.2 0.72 0.28 (0.04)
8162.9 48.5 0.6 1.00 0.00 (0.00)
coproporphyrin fractions revealed a maximal stand-
ard deviation of 0.10 each; thus, concentrations of
uroporphyrin and coproporphyrin can be calculated
accurately enough for clinical interpretation.
A linear relationship between the second-derivative
area under the x-axis and the quantity of porphyrins
was shown by using dilutions of urine specimens
containing high concentrations of porphyrins. The
relationship was linear to at least 10000 nmol/1. As
it is impossible to obtain results for a blank by using
a second-derivative method, we established an arbi-
trary detection limit of 20 nmol/1. Repeated assay of
urine specimens with concentrations near to 20 nmol/1
yielded coefficients of variation of 5%.
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Haemoglobin at 100 mg/1 and bilirubin at 100 μιηοΐ/ΐ
did not distort the shape of the derivative spectra,
and therefore had no influence on the accuracy of the
determination.
Contrary to the results of Westerlund et al. (10) we
found no significant difference in the efficacy of oxi-
dation by hydrogen peroxide or iodine (Mann-Whit-
wey-U-test; p > 0.1). Porphyrin concentrations of aci-
dified urine samples were equally enhanced by addi-
tion of H2O2 or iodine.
Table 4 gives the results of the comparison study. The
results obtained by our method correlated well with
those from the HPLC-method (14) (r2 = 0.99) and
from the ion-exchange method of Doss (15)
(r2 = 0.99).
Tab. 4. Comparison of results of porphyrin measurement by
second-derivative spectrophotometry (y) in both nor-
mal and pathological urine samples with those from
high performance liquid chromatography (HPLC) (xO






































































































Regression lines: y = 1.32xj — 172
y = 1.49 x2 - 59
Discussion
Clinical features of porphyria are variable and often
vague. Diagnosis depends heavily on chemical anal-
ysis of excretion products. For that reason a lot of
urine samples enter clinical laboratories to be assayed
for porphyrins. As urine from someone with porphy-
ria contains much higher amounts of porphyrins than
normal urine, it is quite easy to distinguish positive
cases from negative cases. For urine porphyrin meas-
urement many laboratories still use methods involving
Chromatographie separations. These procedures are
time-consuming and therefore not useful for fast
screening of urine samples, in contrast to the spectro-
photometric measurement of porphyrins, which is
very fast and easy. In recent studies (17) a fairly simple
screening-test involving spectrophotometric scanning
showed excellent performance.
By using second-derivative spectrophotometry and
computerization our method is faster and more ac-
curate than any other screening-test for porphyrins
published so far. Using our computerized method,
results for a urine specimen can be obtained within 5
minutes. The precision of the method has improved
considerably, compared with the results obtained by
Jones & Sweeney (9), especially for low porphyrin
concentrations. The area under the x-axis above the
second-derivative curve proves to be a more reliable
measure of porphyrin concentration than the second-
derivative deflection used by Jones & Sweeney (9).
Whereas the influence of porphyrin composition on
the second-derivative output is neglected by some
authors (18), this factor is integrated in our computer
program and enhances the accuracy of the method.
Precision and recoveries of uro- and coproporphyrin
were at least as good as those by the spectrofluoro-
metric method of Westerlund et al. (10). Some authors
(9, 10) do not mention the porphyrin concentration
and composition of the urine samples used for the
recovery study, although those figures are important
when considering the results of the study.
Estimation of the uro- and coproporphyrin fractions
by the second-derivative minimum is still not perfect,
as an error of 0.4 nm (the step used in our spectra)
in determining the second-derivative minimum can
easily occur. However, the results of the precision
study show that errors greater than 0.10 in uro- and
coproporphyrin fractions will occur only infrequently.
Thus, the estimations of the uro- and coproporphyrin
fractions are considered to be an indication of the
porphyrin composition, and they help to differentiate
coproporphyria from types of porphyria in which
uroporphyrin predominates.
The results of the comparison study are satisfactory.
However, at low porphyrin levels, the differences be-
tween the results are relatively large, especially for
urine no. 11. We attribute this to the large CV-values
(10 — 20%) of the Chromatographie assays and the
inaccurate methods for calculation of the porphyrin
concentration used in those assays, which are clearly
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critical at low porphyrin levels. At high porphyrin
levels, values obtained by the Chromatographie meth-
ods are lower, which might be due to incomplete
extraction.
Chromatographie methods will certainly retain their
value for differential diagnosis of porphyrias; differ-
entiation into uro- and coproporphyrin by spectro
photometric methods becomes impossible especially
when intermediate forms of porphyrin are present in
an urine sample (19, 20). In other cases, such as acute
porphyria during remission, and erythropoietic pro-
toporphyria, the level of urinary porphyrin is normal.
However, spectrophotometric methods for detection
of elevated urinary porphyrin levels are valuable for
screening purposes.
Although some screening tests for porphyria have
proved their capacity to differentiate positive cases
efficiently from negative cases, we think it is preferable
to use a test that combines efficiency with accuracy.
Our method combines the ease of a rapid screening
procedure with accurate determination of the total
urinary porphyrin concentration. Every laboratory
supplied with a spectrophotometer and an attached
microcomputer, can easily adapt this method and
benefit from its great clinical usefulness.
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